Sandeep Vishwanath Kamath

Title: Sandeep Vishwanath Kamath: Innovator in Recombinant Human Insulin Crystallization

Introduction

Sandeep Vishwanath Kamath is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of biochemistry, particularly in the crystallization of recombinant human insulin. His innovative methods have the potential to enhance the manufacturing processes of this essential medication.

Latest Patents

Sandeep holds a patent for the "Preparative crystallization of recombinant human insulin." This invention discloses a method for crystallizing recombinant human insulin at both lab and manufacturing scales. The process involves the use of a mixture of zinc chloride and sodium chloride, along with a higher concentration of organic solvent (IPA-19 to 25 million). Additionally, the pH is adjusted to 5.0 at a faster rate of ≤5 minutes. The method also includes procedures that reduce settling time and alter holding temperature to facilitate consistent protein crystal formation between 15 μm-30 μm, thereby increasing the robustness of the process. He has 1 patent to his name.

Career Highlights

Sandeep is currently employed at Biocon Limited, a leading biopharmaceutical company in India. His work focuses on developing innovative solutions that improve the efficiency and effectiveness of insulin production. His expertise in biochemistry and patentable inventions has positioned him as a valuable asset in the field.

Collaborations

Sandeep has collaborated with notable colleagues such as Arul Marimuthu and Sethumadhavan Sankaran. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sandeep Vishwanath Kamath is a distinguished inventor whose work in the crystallization of recombinant human insulin has the potential to revolutionize the biopharmaceutical industry. His contributions reflect a commitment to advancing medical science and improving patient outcomes.